<DOC>
	<DOCNO>NCT01822639</DOCNO>
	<brief_summary>The study design estimate bioavailability amlodipine enalapril maleate fix dose combination ( FDC ) relative co-administration amlodipine enalapril maleate tablet . The rational study provide convenient dose regimen patient . This open-label , randomize , single dose , two-way crossover study , 16 healthy adult male female subject enrol dosed fasting condition . Each subject participate two treatment period 7 day . There least 14 day wash period two dose period follow-up period 21 day treatment period 2 . The total duration study approximately 35 day start first treatment .</brief_summary>
	<brief_title>A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>Inclusion Criteria Male female age 18 65 year age inclusive , time signing informed consent . Healthy determine responsible experienced physician , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . A subject clinical abnormality laboratory parameter ( ) is/are specifically list inclusion exclusion criterion , outside reference range population study may include Investigator , consultation GlaxoSmithKline ( GSK ) Medical Monitor require , agree document find unlikely introduce additional risk factor interfere study procedure . Body weight &gt; =50 kilogram ( kg ) Body Mass Index within range 19 32 kg/meter square ( m^2 ) ( inclusive ) . A female subject eligible participate nonchildbearing potential define premenopausal female document tubal ligation hysterectomy [ definition , `` document '' refers outcome investigator's/designee 's review subject 's medical history study eligibility , obtain via verbal interview subject subject 's medical record ] ; postmenopausal define 12 month spontaneous amenorrhea [ questionable case blood sample simultaneous follicle stimulate hormone &gt; 40 milli international unit ( MlU ) / milliliter ( mL ) estradiol &lt; 40 picogram/mL ( &lt; 147 picomoles/liter ) confirmatory ] . OR Childbearing potential negative pregnancy test determine serum human chorionic gonadotropin test screen prior dosing . Agrees use one contraception method appropriate period time ( determined product label investigator ) prior start dose sufficiently minimize risk pregnancy point . Female subject must agree use contraception followup contact visit . OR samesex partner , prefer usual lifestyle . Male subject female partner childbearing potential must agree use one contraception method This criterion must follow time first dose study medication followup contact visit . Capable give write informed consent , include compliance requirement restriction list consent form . Alanine aminotransferase , alkaline phosphatase bilirubin &lt; =1.5 x upper limit normal ( ULN ) ( isolated bilirubin &gt; 1.5xULN acceptable bilirubin fractionate direct bilirubin &lt; 35 percent ) . Based single average QT duration correct heart rate ( QTc ) value triplicate electrocardiogram ( ECGs ) obtain brief recording period : QTc Fridericia 's formula &lt; 450 millisecond ( msec ) . Exclusion Criteria Based Upon Medical Histories Current chronic history liver disease , know hepatic biliary abnormality ( With exception Gilbert 's syndrome asymptomatic gallstone ) . History regular alcohol consumption within 6 month study define An average weekly intake &gt; 21 unit male &gt; 14 unit female . In Australia one unit ( =standard drink ) equivalent 10 gram alcohol : 270 mL full strength beer ( 4.8 percent ) , 375 mL mid strength beer ( 3.5 percent ) , 470mL light beer ( 2.7 percent ) , 250 mL premix full strength spirit ( 5 percent ) , 100 mL wine ( 13.5 percent ) 30 mL spirit ( 40 percent ) . History sensitivity study medication , component thereof history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . Exclusion Criteria Based Upon Diagnostic Assessments A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen . Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month prior screen . A positive prestudy drug/alcohol screen . A positive test human immuno virus antibody . Pregnant female determine positive serum hCG test screening time point . Any subject systolic blood pressure &lt; 95 millimeter mercury ( mmHg ) recent history postural symptom . Orthostatic event screening , define symptomatic event ( i.e . dizziness pre syncope syncope ) reduction systolic blood pressure 20mmHg and/or reduction diastolic blood pressure 10 mmHg stand versus supine measurement . Other Exclusion Criteria Where participation study would result donation blood blood product excess 500 mL within 56 day period . Lactating female . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior first dose day . Unable refrain use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . Subject mentally legally incapacitate . Positive carbon monoxide admission Unit . Unable refrain consumption red wine , seville orange , grapefruit grapefruit juice ( and/or pummelo , exotic citrus fruit , grapefruit hybrid fruit juice ) 7 day prior first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>enalapril maleate</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>amlodipine</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>